Xiidra Approved on January 20, 2017

Posted in Latest News on January 20, 2017.

Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.

← Previous Post Next Post →

More Latest News

Important Information on Fraudulent Emails to Practitioners
August 1, 2023

The Department of Health, Division of Medical Quality Assurance, is warning Florida health care practitioners about fraudulent emails that have been received by multiple licensees. Continue reading →

New Legislation Impacting Your Profession
June 28, 2023

Click here to view a full list of bill summaries from the 2023 Florida Legislative Session that may impact your profession. Continue reading →